Board of Directors

Denis R. Burger, Ph.D.

Denis R. Burger, Ph.D., is a director and executive chairman of BioCurex since September 2009. Prior to joining BioCurex, he had been managing director of Sovereign Ventures, LLC, a biotech investing and consulting firm, since 1991. Dr. Burger was chairman and chief executive officer of AVI BioPharma, Inc., a drug development company using gene targeted therapeutics, from 1997 to 2007 and founding chirman of Epitope, Inc., a developer of diagnostic products, from 1981 to 1990. He is currently a director of Trinity Biotech PLC, a diagnostic products develpoer and Lorus Therapeutics, a cancer therapeutics company. Earlier in his career, he was a Professor of Microbiology and Immunology, and Associate Pofessor of Surgery and the Director of Histocompatibility Testing Laboratory at Oregon Health Sciences University.

Dr. Burger holds a B.A. degree in Bacteriology and Immunology from the Univeristy of California at Berkeley, a M.S. and Ph.D. in Microbiology and Immunology from the Univeristy of Arizona, Tucson.